MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
1.500
+0.020 (1.35%)
At close: Sep 17, 2025, 4:00 PM EDT
1.520
+0.020 (1.33%)
After-hours: Sep 17, 2025, 7:03 PM EDT
MaxCyte Market Cap
MaxCyte has a market cap or net worth of $159.91 million as of September 17, 2025. Its market cap has decreased by -64.70% in one year.
Market Cap
159.91M
Enterprise Value
50.79M
1-Year Change
-64.70%
Ranking
Category
Stock Price
$1.50
Market Cap Chart
Since the IPO on March 10, 2021, MaxCyte's market cap has decreased from $494.67M to $159.91M, a decrease of -67.67%. That is a compound annual growth rate of -22.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 157.78M | -64.12% |
| Dec 31, 2024 | 439.69M | -9.93% |
| Dec 29, 2023 | 488.14M | -12.55% |
| Dec 30, 2022 | 558.17M | -45.87% |
| Dec 31, 2021 | 1.03B | 108.47% |
| Mar 10, 2021 | 494.67M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.51B |
| Johnson & Johnson | 424.98B |
| AbbVie | 382.04B |
| UnitedHealth Group | 307.73B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 231.06B |